30
Participants
Start Date
April 6, 2021
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Sacituzumab Govitecan-hziy
Administered intravenously
RECRUITING
Christiana Care Health Services, Newark
RECRUITING
University of Maryland, Baltimore
RECRUITING
Institut Bergonie Medical Oncology, Bordeaux
RECRUITING
Centre Leon Berard, Lyon
RECRUITING
Oncology Consultants, P.A., Houston
RECRUITING
The University of Texas M.D. Anderson Cancer Center, Houston
RECRUITING
Texas Liver Institute, San Antonio
RECRUITING
NEXT Oncology, San Antonio
WITHDRAWN
NEXT Austin, Austin
SUSPENDED
Pacific Shores Medical Group, Long Beach
Lead Sponsor
Gilead Sciences
INDUSTRY